Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
University of Pittsburgh
University of Pittsburgh
Eli Lilly and Company
M.D. Anderson Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
University of Pittsburgh
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
EpicentRx, Inc.